HEAD-TO-HEAD COMPARISON OF SUBCUTANEOUS ABATACEPT VERSUS ADALIMUMAB ON BACKGROUND METHOTREXATE IN RHEUMATOID ARTHRITIS: BLINDED TWO-YEAR RESULTS FROM THE AMPLE STUDY

被引：0
|
作者：
Weinblatt, Michael E. [1 ]
Schiff, Michael H. [2 ]
Valente, Robert [3 ]
van der Heijde, Desiree [4 ]
Citera, Gustavo [5 ]
Elegbe, Ayanbola [6 ]
Maldonado, Michael A. [7 ]
Fleischmann, Roy [8 ]
机构：
[1] Brigham & Womens Hosp, Dept Rheumatol & Immunol, Boston, MA 02115 USA
[2] Univ Colorado, Div Rheumatol, Denver, CO USA
[3] Arthritis Ctr Nebraska, Dept Rheumatol, Lincoln, NE USA
[4] Leiden Univ, Med Ctr, Dept Rheumatol, Leiden, Netherlands
[5] Inst Rehabil Psicofis, Rheumatol Sect, Buenos Aires, DF, Argentina
[6] Bristol Myers Squibb, Dept Global Biometr Sci, Princeton, NJ USA
[7] Bristol Myers Squibb, Dept Med Affairs, Princeton, NJ USA
[8] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA
来源：
RHEUMATOLOGY | 2014年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
86
引用
收藏
页码：88 / 88
页数：1
相关论文
共 50 条
  • [1] Head-To-Head Comparison of Subcutaneous Abatacept Versus Adalimumab on Background Methotrexate in RA: Blinded Two-Year Results from the AMPLE (Abatacept Versus Adalimumab Comparison in Biologic-Naive RA Subjects with Background Methotrexate) Study
    Weinblatt, Michael
    Schiff, Michael
    Valente, Robert
    van der Heijde, Desiree
    Citera, Gustavo
    Elegbe, Ayanbola
    Maldonado, Michael
    Fleischmann, Roy
    [J]. JOURNAL OF RHEUMATOLOGY, 2014, 41 (07) : 1476 - 1476
  • [2] HEAD-TO-HEAD COMPARISON OF SUBCUTANEOUS ABATACEPT VERSUS ADALIMUMAB ON BACKGROUND METHOTREXATE IN RA: TWO YEAR RESULTS FROM THE AMPLE STUDY
    Schiff, M.
    Weinblatt, M.
    Valente, R.
    van der Heijde, D.
    Citera, G.
    Elegbe, A.
    Maldonado, M.
    Fleischmann, R.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 64 - 64
  • [3] Head-To-Head Comparison Of Subcutaneous Abatacept Versus Adalimumab On Background Methotrexate In RA: Blinded Two Year Results From The Ample (Abatacept Versus Adalimumab Comparison in Biologic-Naive RA Subjectswith Background Methotrexate) study
    Weinblatt, Michael E.
    Schiff, Michael H.
    Valente, Robert
    van der Heijde, Desiree M.
    Citera, Gustavo
    Elegbe, Ayanbola
    Maldonado, Michael A.
    Fleischmann, Roy M.
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S991 - S992
  • [4] Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: two-year efficacy and safety findings from AMPLE trial
    Schiff, Michael
    Weinblatt, Michael E.
    Valente, Robert
    van der Heijde, Desiree
    Citera, Gustavo
    Elegbe, Ayanbola
    Maldonado, Michael
    Fleischmann, Roy
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (01) : 86 - 94
  • [5] Head-to-Head Comparison of Subcutaneous Abatacept Versus Adalimumab in the Treatment of Rheumatoid Arthritis: Key Efficacy and Safety Results from the AMPLE (Abatacept Versus Adalimumab Comparison in Biologic-Naive RA Subjects with Background Methotrexate) Trial
    Maldonado, Michael
    Weinblatt, Michael
    Schiff, Michael
    Fleischmann, Roy
    Valente, Robert
    Van der Heijde, Desiree
    Citera, Gustavo
    Zhao, Cathy
    [J]. JOURNAL OF RHEUMATOLOGY, 2013, 40 (06) : 1005 - 1006
  • [6] Patient-Reported Outcomes From a Two-Year Head-to-Head Comparison of Subcutaneous Abatacept and Adalimumab for Rheumatoid Arthritis
    Fleischmann, Roy
    Weinblatt, Michael E.
    Schiff, Michael
    Khanna, Dinesh
    Maldonado, Michael A.
    Nadkarni, Anagha
    Furst, Daniel E.
    [J]. ARTHRITIS CARE & RESEARCH, 2016, 68 (07) : 907 - 913
  • [7] Head to Head Comparison of Subcutaneous Abatacept Versus Adalimumab in the Treatment of Rheumatoid Arthritis: Key Efficacy and Safety Results From the Ample (Abatacept Versus Adalimumab Comparison in Biologic-Naive RA Subjects with Background Methotrexate) Trial
    Weinblatt, Michael E.
    Schiff, Michael H.
    Fleischmann, Roy
    Valente, Robert
    van der Heijde, Desiree
    Citera, Gustavo
    Zhao, Cathy
    Maldonado, Michael A.
    [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S1031 - S1031
  • [8] HEAD-TO-HEAD COMPARISON OF SUBCUTANEOUS ABATACEPT VS ADALIMUMAB IN THE TREATMENT OF RHEUMATOID ARTHRITIS: KEY EFFICACY AND SAFETY RESULTS FROM THE AMPLE TRIAL
    Weinblatt, Michael E.
    Schiff, Michael H.
    Fleischmann, Roy
    Valente, Robert
    van der Heijde, Desiree
    Citera, Gustavo
    Zhao, Cathy
    Maldonado, Michael A.
    [J]. RHEUMATOLOGY, 2013, 52 : 45 - 46
  • [9] COST COMPARISON OF ABATACEPT AND ADALIMUMAB BASED ON AMPLE, A 2-YEAR HEAD-TO-HEAD OUTCOMES STUDY IN RHEUMATOID ARTHRITIS
    Gaultney, J.
    Budd, D.
    Nappi, C.
    Benucci, M.
    Iannazzo, S.
    Alemao, E.
    Sabater, J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 551 - 552
  • [10] Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: Findings of a phase IIIb, multinational, prospective, randomized study
    Weinblatt, Michael E.
    Schiff, Michael
    Valente, Robert
    van der Heijde, Desiree
    Citera, Gustavo
    Zhao, Cathy
    Maldonado, Michael
    Fleischmann, Roy
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 (01): : 28 - 38
12345